title: Evaluating the effectiveness of smoking cessation in the management of COPD.
abstract: The aim of this literature review is to assess the effectiveness of smoking cessation in managing patients with chronic obstructive pulmonary disease (COPD). COPD is the fifth leading cause of death in the world and smoking leads to COPD in more than 80% of cases. Smoking cessation aids are considered the most effective intervention to improve quality of life and prevent further deterioration in COPD. Evidence based on the use of pharmacotherapies, patient support and motivation as part of smoking cessation strategies were evaluated and discussed. The findings demonstrate that pharmacotherapies, support and counselling in smoking cessation help reduce hospital stay and hospitalisation and improve symptoms and quality of life. In addition, nurses need more education on how to use open-ended questions and motivation when giving advice on smoking cessation to patients with COPD.
authors.affiliation: Acute Hospital Inspector, Care Quality Commission, Newcastle.
authors.forename: Isimat
authors.initials: I
authors.lastname: Temitayo Orisasami
authors.affiliation: Senior Lecturer in Primary Care, Faculty of Education and Health, University of Greenwich.
authors.forename: Omorogieva
authors.initials: O
authors.lastname: Ojo
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D016642:Bupropion / Q000627:therapeutic use; D003376:Counseling; D006801:Humans; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D024802:Nurse's Role; D029424:Pulmonary Disease, Chronic Obstructive / Q000451:nursing*; D012907:Smoking / Q000628:therapy*; D016540:Smoking Cessation; D012944:Social Support; D061485:Tobacco Use Cessation Devices; D000068580:Varenicline / Q000627:therapeutic use
chemical_list: D018687:Antidepressive Agents, Second-Generation; D018722:Nicotinic Agonists; D016642:Bupropion; D000068580:Varenicline
keywords: COPD; Counselling; Patient support; Pharmacotherapies; Smoking cessation